Moderna
MRNA
#1132
Rank
NZ$35.39 B
Marketcap
NZ$89.24
Share price
3.60%
Change (1 day)
92.08%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -NZ$4.73 Billion

According to Moderna 's latest financial reports the company's current earnings are NZ$1.92 Billion. , an increase over its 2024 earnings that were of -NZ$6.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$4.75 Billion-23.03%
2024 -NZ$6.16 Billion-8.22%
2023 -NZ$6.72 Billion-140.65%
2022 NZ$16.50 B-27.81%
2021 NZ$22.86 B-1911.15%
2020 -NZ$1.27 Billion44.7%
2019 -NZ$0.88 Billion28.63%
2018 -NZ$0.68 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$57.67 B-1,316.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.10 B-692.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$38.54 B-913.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-NZ$81.54 Million-98.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$71.79 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.98 B-120.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$0.59 B-112.51%๐Ÿ‡บ๐Ÿ‡ธ USA